The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam earlier this month, heard.
Statement of Intersex Asia and Asian intersex forum
US: The Discrimination LGBTQ People Still Face from Healthcare Providers
France: HPV16 highly prevalent among HIV-positive MSM
Although a third of anal cancers in HIV-positive patients did not contain HPV16, no other single HPV type predominated in these cancers. The authors of the meta-analysis believe their findings have implications for HPV vaccination strategies in patients with HIV, concluding “nine-valent would provide a larger gain in HIV-positive than HIV-negative individuals.”